Swift Biosciences nails down $3M in VC
Usually a few million dollars in venture capital doesn’t go all that far with life sciences start-ups, but Swift Biosciences expects to stretch its $3 million in seed capital all the way to commercialization.”We expect to have products ready for the market with this money,” says David Olson, president and CEO of Swift Biosciences.The Ann Arbor-based start-up is developing molecular biology reagents for research and diagnostic applications that provide new ways to examine disease-related genes. This technology is expected to help researchers analyze samples faster, at a higher volume, and at a lower price-per-sample.The 1-year-old firm started with two people and now employs four. It is in the process of hiring a fifth. It expects to make two more hires within the next six months as it ramps up research, development, and commercialization of its product. Houston-based DFJ Mercury led the latest round of fundraising and helped form the company at its outset.Source: David Olson, president and CEO of Swift BiosciencesWriter: Jon Zemke
Usually a few million dollars in venture capital doesn’t go all that far with life sciences start-ups, but Swift Biosciences expects to stretch its $3 million in seed capital all the way to commercialization.
“We expect to have products ready for the market with this money,” says David Olson, president and CEO of Swift Biosciences.
The Ann Arbor-based start-up is developing molecular biology reagents for research and diagnostic applications that provide new ways to examine disease-related genes. This technology is expected to help researchers analyze samples faster, at a higher volume, and at a lower price-per-sample.
The 1-year-old firm started with two people and now employs four. It is in the process of hiring a fifth. It expects to make two more hires within the next six months as it ramps up research, development, and commercialization of its product. Houston-based DFJ Mercury led the latest round of fundraising and helped form the company at its outset.
Source: David Olson, president and CEO of Swift Biosciences
Writer: Jon Zemke
Related Articles
Recast Leaders aim to revitalize local economies
Ypsilanti and six other Michigan communities are working on building their local economies in the Recast Leaders program. Here’s a look at how the program works.
AI’s impact in Washtenaw County, from tech boom to data centers
Our new three-part series digs into AI’s impacts in Ann Arbor’s tech industry, its utilization in Washtenaw County’s educational world, and the ongoing debate about data centers in several Washtenaw County communities.
Ypsi selected to join downtown revitalization program with emphasis on small manufacturers
Ypsilanti is one of six communities participating in Recast City’s Recast Leaders program, which is focused on strengthening local economies through small-scale manufacturing and product-based businesses.
